Restricted accessLetterFirst published online 2026-2
Letter: Use of an Advanced Hybrid Closed-Loop Insulin Delivery System in a Hemodialysis Patient with Type 1 Diabetes and Anorexia Nervosa: A Case Report
Goebel-FabbriAE, FikkanJ, FrankoDL, et al.Insulin restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes Care, 2008; 31(3):415–419; doi: 10.2337/dc07-2026
2.
ColtonP, OlmstedM, DanemanD, et al.Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: A case-controlled study. Diabetes Care, 2004; 27(7):1654–1659; doi: 10.2337/diacare.27.7.1654
3.
HayashiA, ShimizuN, SuzukiA, et al.Hemodialysis-Related glycemic disarray proven by continuous glucose monitoring: Glycemic markers and hypoglycemia. Diabetes Care, 2021; 44(7):1647–1656; doi: 10.2337/dc21-0269
4.
TauschmannM, AllenJM, WilinskaME, et al.Day-and-Night hybrid closed-loop insulin delivery in adolescents with type 1 diabetes: A free-living, randomized clinical trial. Diabetes Care, 2016; 39(7):1168–1174; doi: 10.2337/dc15-2078
5.
BoughtonCK, TripylaA, HartnellS, et al.Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: An open-label, randomized crossover trial. Nat Med, 2021; 27(8):1471–1476; doi: 10.1038/s41591-021-01453-z
